Number 28

Senior, elderly, geriatric: we are all getting older

Editorial 1 January 2009 0

Politically correct wording seems to be a must, and in many areas this leads to variously differing solutions, which can all be criticised. But a fact is a fact, and hiding it behind ‘nicer’ words [more]

... [ more ]

Jean-Pierre Droz: We can do better for our older patients

Cover Story 1 January 2009 0

Cancer is classically a disease of the elderly, yet all too often the special needs of older patients seem to be ignored. Routine use of screening to distinguish patients healthy enough to receive standard therapy [more]

... [ more ]

Combining hormonal therapy with local treatment in prostate cancer

Grandround 1 January 2009 0

Hormonal treatment remains a main stay of systemic therapy for prostate cancer despite recent developments in chemotherapy and intensive research with targeted drugs and immunotherapy. Its efficacy in palliative management of advanced disease has prompted [more]

... [ more ]

Oncology’s successes must not fail the heart

Senza categoria 1 January 2009 0

Targeted therapies seek to close down signalling pathways that allow tumours to prosper. But these pathways may also be vital to other clinical functions. With rising concern about collateral cardiac damage from cancer treatment comes [more]

... [ more ]

Siding with the vulnerable

Senza categoria 1 January 2009 0

Silvio Monfardini’s great contribution to oncology has been raising the standard of care for older patients. His story is a shining example of what can be achieved when scientific rigour is combined with a deep-rooted [more]

... [ more ]

Everyone deserves the best chance to survive

Senza categoria 1 January 2009 0

When it comes to cancer, newspapers tend to home in on tragic stories of young mothers or children. The big story of the explosion of cancer cases among the elderly and the urgent need for [more]

... [ more ]

Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma

Impact Factor 1 January 2009 0

The adoptive transfer of antigen-specific CD4+ cells is a feasible treatment for cancer and provides critical insight into immune mechanisms involved in durable clinical responses. Download full article

... [ more ]

Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer

Impact Factor 1 January 2009 0

Postoperative radiotherapy with or without chemotherapy remains part of the standard treatment regimen to improve locoregional control for patients with head and neck cancer who have adverse pathologic factors after surgery. Whether an overall survival [more]

... [ more ]

Newsround

Senza categoria 1 January 2009 0

Selected reports edited by Janet Fricker Download full article

... [ more ]

The root of all evil?

Focus 1 January 2009 0

Cancer may be caused by stem cells gone bad. If that proves to be correct, it should revolutionise treatment. Download full article

... [ more ]